Effect of Pre-operative Oral Hydration on Post-operative Pain and Nausea in Adults Undergoing Tonsillectomy
NCT ID: NCT05507918
Last Updated: 2024-04-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2024-04-30
2025-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Measuring Pain and Hydration After Tonsillectomy
NCT02011230
Opioid Sparing Anesthesia Care for Pediatric Patients Having Tonsil Surgery
NCT06326983
Effect of Intraoperative Crystalloid Volume on Postoperative Vomiting
NCT02177201
Acetaminophen's Efficacy For Post-operative Pain
NCT01721486
The Effect of Intravenous Lidocaine on Pain After Tonsillectomy
NCT01291979
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The goal of this study is to evaluate if the amount of pre-operative oral hydration can reduce the amount of pain and nausea/vomiting in patients undergoing adult tonsillectomies. This study will be measuring post-operative pain and nausea scores at several points after the adult tonsillectomy procedure for participants that have consumed different amounts of clear fluid in the 24 hours leading up to their nothing by mouth (NPO) status. Participants will be randomized to one of three categories of preoperative fluid: 0.5 - 1.5 Liters (L), 1.5 - 3 L, and 3 - 4.5 L, which will correlate to the low, medium and high fluid intake groups, respectively. Participants will be given a 1000 mL measuring water bottle that they can use to accurately record their fluid consumption in the 24 hours prior to their pre-operative NPO status. The fluid consumption that they record will include all liquids (i.e., water, flavored water, juice, coffee, tea, soda, milk, alcohol). They will be asked to keep a record of the volume of caffeinated beverage versus un-caffeinated beverages.
After surgery the participants will be given a form to record their pain and nausea scores. Participants will record their pain and nausea by using two separate 10-point scales at 7 different points after the procedure. These scores will be measured immediately after surgery, and at 4 hours, 8 hours, 24 hours, 72 hours, 5 days and 7 days postoperative. This form, along with a count of opioid medication used, will be retuned to the physician at the first post-operative follow-up visit.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low fluid intake
0.5 L - 1.5 L fluid intake in the 24 hours prior to NPO status for surgery
Oral water and clear liquids
Measured oral intake of fluids prior to tonsillectomy
Medium fluid intake
1.5 L - 3 L fluid intake in the 24 hours prior to NPO status for surgery
Oral water and clear liquids
Measured oral intake of fluids prior to tonsillectomy
High fluid intake
3 L - 4.5 L fluid intake in the 24 hours prior to NPO status for surgery
Oral water and clear liquids
Measured oral intake of fluids prior to tonsillectomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oral water and clear liquids
Measured oral intake of fluids prior to tonsillectomy
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients greater than or equal to 18 years of age
Exclusion Criteria
* Decisionally impaired
* Adults with history of significant gastro-esophageal pathology (ie. gastric/duodenal ulcers, Barrett's esophagus, eosinophilic esophagitis)
* Patient undergoing tonsillectomy procedure due to previous or active peri-tonsillar abscess or for resection of cancer
* Allergy or contraindication to the use of acetaminophen or narcotic medications
* Pregnant
* Patients that have chronic disease states including chronic kidney disease, congestive heart failure, diabetes mellitus, diabetes insipidus, or chronic pain syndrome
* Patients that are on chronic pain medications, diuretics or steroids
* Patients that have history of significant nausea/vomiting associated with anesthesia
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
William Beaumont Hospitals
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Matthew Farrugia
Program Director, Otolaryngology Head and Neck Residency Program
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Matthew Farrugia, DO
Role: PRINCIPAL_INVESTIGATOR
Beaumont Health - Farmington Hills
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.